Archives

Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Iovance Biotherapeutics Inc (NASDAQ:IOVA) achieved...

• February 28, 2025 07:37 AM GMT
• EODHD

Core EPS for Q4 2024: $1.05 Full Year 2024 Core EPS: $4.93, above the midpoint of guidance 2025 EPS Guidance: Revised range of $5.50 to $5.90, plus $0.44 from TKM settlement Dividend: First Quarter 20...

• February 28, 2025 07:35 AM GMT
• EODHD

Sales per Square Foot: $837 at the end of Q4 2024, up $3 from the previous quarter. Occupancy Rate: 94.1% in Q4 2024, up 40 basis points from Q3 and 60 basis points year-over-year. New Store Openings:...

• February 28, 2025 07:33 AM GMT
• EODHD

Net Income (Q4 2024): $0.43 per diluted share, down from $0.73 per diluted share in Q4 2023. Interest Income (Q4 2024): $32.3 million, up from $16.9 million in Q4 2023. Interest Expense (Q4 2024): Dec...

• February 28, 2025 07:31 AM GMT
• EODHD

Friday 28 February, 2025 Vooglam, an online eyewear brand with a unique design ethos, is revolutionizing the way customers shop for glasses with a series of user-friendly updates to its product pages....

• February 28, 2025 07:30 AM GMT
• Pressat

Friday 28 February, 2025 Nigeria – The Nigerian Upstream Petroleum Regulatory Commission (NUPRC) has welcomed a landmark ruling by the Federal High Court in Yenagoa, which upholds the legal integrity...

• February 28, 2025 07:30 AM GMT
• Pressat

Is ATOME PLC's Funding Deal Set to Transform the Green Fertilizer Landscape?

• February 28, 2025 07:30 AM GMT
• Team Kalkine Media

Post-Op Shoe Size, Share, and Trend Analysis On the basis of end user, the post-op shoe for adult is expected to grow at a CAGR of 5.2% during the forecast period. WILMINGTON, DE, UNITED STATES, Febru...

• February 28, 2025 07:27 AM GMT
• EIN Presswire

Attributed Cash and Liquid Investments: $2.6 billion at year-end, including $1.3 billion at F1 and $78 million at Quint. Total Debt: $2.9 billion, with $2.4 billion at F1 and $528 million at the corpo...

• February 28, 2025 07:25 AM GMT
• EODHD

Net Income per Diluted Share: $4.96 for Q4 2024; Adjusted net income per diluted share: $4.92. Same-Facility Adjusted Admissions (Acute Care): Increased by 2.2% in Q4 2024. Same-Facility Net Revenues...

• February 28, 2025 07:24 AM GMT
• EODHD